BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/10/2026 7:17:45 AM | Browse: 4 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Stage-dependent prognostic value of programmed death ligand-1 expression in gastric cancer: Implications for personalized immunotherapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Koji Takahashi |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Koji Takahashi, MD, Department of Gastroenterology, Eastern Chiba Medical Center, 3-6-2, Okayamadai, Togane City 283-8686, Japan. koji517@gmail.com |
| Key Words |
Gastric cancer; Programmed death ligand-1; Prognosis; Tumor microenvironment; Immunotherapy; Pathological stage; Chemotherapy; Gastroesophageal junction cancer |
| Core Tip |
The study by Zhang et al identifies a crucial stage-dependent prognostic role of programmed death ligand-1 (PD-L1) in gastric cancer, aligning with clinical observations from the KEYNOTE-585 trial. While high PD-L1 predicts poor prognosis in stage III, its role in stage II remains distinct, possibly due to differing immune surveillance states. This highlights that PD-L1 expression should not be evaluated in isolation but within the context of tumor-node-metastasis staging and the broader tumor microenvironment to optimize precision immunotherapy strategies. |
| Citation |
Takahashi K. Stage-dependent prognostic value of programmed death ligand-1 expression in gastric cancer: Implications for personalized immunotherapy. World J Gastroenterol 2026; In press |
 |
Received |
|
2026-01-12 03:01 |
 |
Peer-Review Started |
|
2026-01-12 03:02 |
 |
First Decision by Editorial Office Director |
|
2026-01-23 10:05 |
 |
Return for Revision |
|
2026-01-23 10:05 |
 |
Revised |
|
2026-01-31 02:01 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-03-10 02:50 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-10 07:17 |
 |
Articles in Press |
|
2026-03-10 07:17 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345